Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals Misses on Revenue, Stock Up 4.69%

Corvus Pharmaceuticals reported a loss of $0.13 per share, with no revenue figures disclosed. Despite the lack of revenue details, the stock reacted positively, rising by 4.69%. This could indicate investor optimism about the company's future prospects or other underlying factors not captured in the earnings report.